Faculty of Medicine and Health, Örebro Universitet, Örebro, Sweden
Department of Biomedical and Clinical Sciences and Wallenberg Center for Molecular Medicine, Linköping University, Linkoping, Sweden.
BMJ Open Diabetes Res Care. 2021 May;9(1). doi: 10.1136/bmjdrc-2020-002033.
Bariatric and metabolic surgery is an effective treatment option for type 2 diabetes (T2D). Increased knowledge regarding factors associated with diabetes remission is essential in individual decision making and could guide postoperative care. Therefore, we aimed to explore factors known to affect the chance of achieving diabetes remission after bariatric and metabolic surgery and to further investigate the impact of socioeconomic factors.
In this nationwide study, we assessed all patients with T2D who underwent Roux-en-Y gastric bypass (RYGB) surgery between 2007 and 2015 in the Scandinavian Obesity Surgery Registry. Remission was defined as absence of antidiabetic medication for T2D 2 years after surgery. Multivariable logistic regression was used to evaluate factors associated with diabetes remission, with missing data handled by multiple imputations.
A total of 8057 patients were included. Mean age±SD was 47.4±10.1 years, mean body mass index 42.2±5.7 kg/m, mean hemoglobin A1c 59.0±17.33, and 61.7% (n=4970) were women. Two years after surgery, 6211 (77.1%) patients achieved T2D remission. Preoperative insulin treatment (OR 0.26, 95% CI 0.22 to 0.30), first-generation immigrant (OR 0.66, 95% CI 0.57 to 0.77), duration of T2D (OR 0.89, 95% CI 0.88 to 0.90), dyslipidemia (OR 0.71, 95% CI 0.62 to 0.81), age (OR 0.97, 95% CI 0.96 to 0.97), and high glycosylated hemoglobin A1c (HbA1c) (OR 0.99, 95% CI 0.98 to 0.99) were all associated with lower T2D remission rate. In contrast, residence in a medium-sized (OR 1.39, 95% CI 1.20 to 1.61) or small (OR 1.46, 95% CI 1.25 to 1.71) town and percentage of total weight loss (OR 1.04, 95% CI 1.03 to 1.04) were associated with higher remission rates.
Among patients with T2D undergoing RYGB surgery, increasing age, HbA1c, and diabetes duration decreased the chance of reaching diabetes remission without cut-offs, while postoperative weight loss demonstrated a positive linear association. In addition, being a first-generation immigrant and living in a large city were socioeconomic factors having a negative association.
减重与代谢手术是治疗 2 型糖尿病(T2D)的有效方法。了解与糖尿病缓解相关的因素对于个体决策至关重要,并且可以指导术后护理。因此,我们旨在探讨与减重与代谢手术后糖尿病缓解相关的因素,并进一步研究社会经济因素的影响。
在这项全国性研究中,我们评估了 2007 年至 2015 年间在斯堪的纳维亚肥胖手术登记处接受 Roux-en-Y 胃旁路术(RYGB)的所有 T2D 患者。术后 2 年糖尿病缓解定义为无需使用抗糖尿病药物。采用多变量逻辑回归评估与糖尿病缓解相关的因素,对于缺失数据采用多重插补处理。
共纳入 8057 例患者。平均年龄±标准差为 47.4±10.1 岁,平均体重指数为 42.2±5.7kg/m2,平均血红蛋白 A1c 为 59.0±17.33,61.7%(n=4970)为女性。术后 2 年,6211(77.1%)例患者达到 T2D 缓解。术前胰岛素治疗(OR 0.26,95%CI 0.22 至 0.30)、第一代移民(OR 0.66,95%CI 0.57 至 0.77)、T2D 病程(OR 0.89,95%CI 0.88 至 0.90)、血脂异常(OR 0.71,95%CI 0.62 至 0.81)、年龄(OR 0.97,95%CI 0.96 至 0.97)和高糖化血红蛋白 A1c(HbA1c)(OR 0.99,95%CI 0.98 至 0.99)均与较低的 T2D 缓解率相关。相反,居住在中型(OR 1.39,95%CI 1.20 至 1.61)或小型城镇(OR 1.46,95%CI 1.25 至 1.71)以及体重减轻百分比(OR 1.04,95%CI 1.03 至 1.04)与较高的缓解率相关。
在接受 RYGB 手术的 T2D 患者中,年龄、HbA1c 和糖尿病病程的增加降低了达到糖尿病缓解的机会,而术后体重减轻呈正线性相关。此外,作为第一代移民和居住在大城市是具有负相关的社会经济因素。